Open-house rebate agreement for Relugolix

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Nov 03, 2027 · 432 days left·Open·Supplies·Framework

Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Relugolix, ATC L02BX04

62/100

Opportunity Score

Needs reviewMedium complexity

SuppliesFrameworkOpen

Why this score?

Opportunity

62 / 100

Complexity

58 / 100

Risk factors

Submitting documents through the wrong portal area is explicitly prohibited; the contract documents must be sent via th...

The latest contract conclusion date is 03.11.2027, and monthly cut-offs apply for next-month start dates.

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

Description
Industries & Services
Capabilities
Market & Experience
Certifications

Overview

Moderate opportunity

Key Facts

Framework procurement
Supplies contract
1 lot
Duration until Dec 2027
Non-exclusive open-house rebate agreements for the active substance Relugolix, ATC L02BX04.
Supply of pharmaceutical products under a pre-defined contract model with no individual negotiation.

Show full summary

Open-house supply arrangement for pharmaceutical products concerning Relugolix (ATC L02BX04) by AOK Bayern. The model is explicitly described as non-exclusive and open to all interested pharmaceutical companies that meet the stated suitability requirement. No estimated contract value is provided. Submission is via DTVP electronic portal with a qualified electronic signature or by paper originals in duplicate; the latest contract conclusion date is 03.11.2027, while the overall contract period runs from 01.01.2026 to 31.12.2027.

Risks

Submitting documents through the wrong portal area is explicitly prohibited; the contract documents must be sent via th...

The latest contract conclusion date is 03.11.2027, and monthly cut-offs apply for next-month start dates.

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Eligibility

Only pharmaceutical companies are eligible as potential contract partners.

Administrative

Submit a signed declaration of reliability (Eigenerklärung zur Zuverlässigkeit).
Submit the completed and signed contract and the completed and signed annex 'Festlegung der vertragsgegenständlichen Arzneimittel'.

Buyer

Name

AOK Bayern - Die Gesundheitskasse

Location

München, DEU

[email protected]

Website

www.aok.de

Buyer profile

Open profile

Identifier

DE811695320

Activity

Health

Lots (1)

LOT-0001

Open-house rebate agreement for Relugolix

Single lot for non-exclusive open-house rebate agreements for the medicinal product Relugolix, ATC L02BX04. Scope is pharmaceutical supplies in Germany (place of performance: DE212 / Bavaria). The lot information comes from structured data and XML notice text.

SuppliesFrameworkEU fundedElectronic submission

Location

DE212, Germany

Duration

Dec 2025 - Dec 2027

Procurement Details

Publication date: 16 Nov 2025
Languages: German

Reference metadata

Legal basis: 32014L0024

Reference IDs

Tender ID: 761915-2025

Documents (2)

Procurement document 1 Submission portal 1

Similar tenders

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3